A detailed history of Csenge Advisory Group transactions in Colgate Palmolive CO stock. As of the latest transaction made, Csenge Advisory Group holds 3,890 shares of CL stock, worth $363,948. This represents 0.02% of its overall portfolio holdings.

Number of Shares
3,890
Previous 3,734 4.18%
Holding current value
$363,948
Previous $362,000 11.33%
% of portfolio
0.02%
Previous 0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$95.54 - $108.77 $14,904 - $16,968
156 Added 4.18%
3,890 $403,000
Q2 2024

Jul 10, 2024

BUY
$85.85 - $98.99 $25,755 - $29,697
300 Added 8.74%
3,734 $362,000
Q1 2024

May 03, 2024

BUY
$79.89 - $90.05 $2,476 - $2,791
31 Added 0.91%
3,434 $309,000
Q4 2023

Feb 13, 2024

SELL
$68.87 - $79.71 $5,509 - $6,376
-80 Reduced 2.3%
3,403 $271,000
Q3 2023

Nov 01, 2023

SELL
$71.05 - $77.96 $10,799 - $11,849
-152 Reduced 4.18%
3,483 $247,000
Q2 2023

Jul 20, 2023

BUY
$74.38 - $81.98 $4,537 - $5,000
61 Added 1.71%
3,635 $280,000
Q1 2023

May 01, 2023

SELL
$71.31 - $79.96 $1,354 - $1,519
-19 Reduced 0.53%
3,574 $268,000
Q4 2022

Feb 10, 2023

SELL
$68.48 - $79.94 $54,510 - $63,632
-796 Reduced 18.14%
3,593 $283,000
Q3 2022

Oct 04, 2022

SELL
$70.25 - $82.95 $13,628 - $16,092
-194 Reduced 4.23%
4,389 $308,000
Q2 2022

Jul 27, 2022

SELL
$73.92 - $82.1 $23,432 - $26,025
-317 Reduced 6.47%
4,583 $367,000
Q1 2022

May 09, 2022

SELL
$72.2 - $85.22 $200,210 - $236,315
-2,773 Reduced 36.14%
4,900 $372,000
Q4 2021

Feb 10, 2022

BUY
$74.42 - $85.34 $178,384 - $204,559
2,397 Added 45.43%
7,673 $627,000
Q3 2021

Oct 20, 2021

SELL
$75.58 - $84.39 $181,165 - $202,282
-2,397 Reduced 31.24%
5,276 $399,000
Q2 2021

Jul 21, 2021

BUY
$78.55 - $84.59 $173,831 - $187,197
2,213 Added 40.53%
7,673 $627,000
Q1 2021

Apr 28, 2021

SELL
$74.44 - $84.52 $91,189 - $103,537
-1,225 Reduced 18.32%
5,460 $436,000
Q4 2020

Jan 26, 2021

SELL
$76.67 - $86.26 $7,360 - $8,280
-96 Reduced 1.42%
6,685 $572,000
Q3 2020

Nov 09, 2020

BUY
$73.03 - $79.47 $29,577 - $32,185
405 Added 6.35%
6,781 $526,000
Q2 2020

Jul 17, 2020

SELL
$65.55 - $74.36 $35,528 - $40,303
-542 Reduced 7.83%
6,376 $467,000
Q1 2020

Apr 21, 2020

SELL
$59.89 - $77.35 $19,584 - $25,293
-327 Reduced 4.51%
6,918 $459,000
Q4 2019

Feb 05, 2020

BUY
$65.41 - $72.07 $117,607 - $129,581
1,798 Added 33.01%
7,245 $499,000
Q3 2019

Nov 14, 2019

BUY
$68.8 - $75.57 $52,632 - $57,811
765 Added 16.34%
5,447 $400,000
Q2 2019

Jul 30, 2019

SELL
$67.55 - $73.99 $1,958 - $2,145
-29 Reduced 0.62%
4,682 $335,000
Q1 2019

May 07, 2019

BUY
$58.97 - $68.54 $294 - $342
5 Added 0.11%
4,711 $322,000
Q4 2018

Feb 07, 2019

BUY
$57.88 - $67.39 $15,338 - $17,858
265 Added 5.97%
4,706 $280,000
Q3 2018

Nov 19, 2018

SELL
$64.58 - $69.09 $200,843 - $214,869
-3,110 Reduced 41.19%
4,441 $277,000
Q2 2018

Aug 10, 2018

BUY
$61.65 - $72.44 $10,048 - $11,807
163 Added 2.21%
7,551 $487,000
Q1 2018

May 10, 2018

BUY
$68.19 - $77.5 $95,738 - $108,810
1,404 Added 23.46%
7,388 $530,000
Q4 2017

Feb 15, 2018

BUY
$69.2 - $75.99 $43,665 - $47,949
631 Added 11.79%
5,984 $452,000
Q3 2017

Oct 31, 2017

BUY
$70.78 - $73.39 $378,885 - $392,856
5,353
5,353 $0

Others Institutions Holding CL

About COLGATE PALMOLIVE CO


  • Ticker CL
  • Exchange NYSE
  • Sector Consumer Defensive
  • Industry Household & Personal Products
  • Shares Outstandng 834,120,000
  • Market Cap $78B
  • Description
  • Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, condition...
More about CL
Track This Portfolio

Track Csenge Advisory Group Portfolio

Follow Csenge Advisory Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Csenge Advisory Group, based on Form 13F filings with the SEC.

News

Stay updated on Csenge Advisory Group with notifications on news.